Mihail Obrocea - 16 Sep 2022 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Chief Medical Officer
Signature
/s/ Mihail Obrocea
Issuer symbol
MAIA
Transactions as of
16 Sep 2022
Net transactions value
$0
Form type
4
Filing time
20 Sep 2022, 11:13:27 UTC
Previous filing
02 Aug 2022
Next filing
10 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +100,000 $0.000000 100,000 16 Sep 2022 Common Stock 100,000 $3.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on September 16, 2022 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months.